India’s first mRNA vaccine against Covid-19 from Gennova gets DCGI approval
Gennova's vaccine will be available for adults above 18 years of age. It will be a two-dose vaccine that will be administered intramuscularly at 28 days apart
covovax
June 2022
April 2022
December 2021
January 2021
Serum not making fresh vaccines amid surplus stock: Poonawalla
Serum Institute chief executive Adar Poonawalla, during a media event today, said the company has 200 million doses of vaccine stock available currently.
Covid-19: 2 new vaccines, 1 drug join fight against virus in India
Covid-19 vaccines Corbevax and Covovax, and anti-viral medication Molnupiravir have been granted emergency use authorisation by the CDSCO.
Serum's new Covid vaccine Covovax gets WHO nod
WHO chief scientist Soumya Swaminathan congratulated Serum Institute, Adar Poonawalla and Novavax for offering one more highly effective and safe vaccine.
With five vaccines, Serum set for global race
Besides Covishield, four more Covid-19 vaccines are under preparation at the world’s largest vaccine company in Pune as demand from across the globe spikes.
